Skip to Main Content (Press Enter)

Logo UNILINK
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture

UNI-FIND
Logo UNILINK

|

UNI-FIND

unilink.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  1. Pubblicazioni

Rebalance the oral microbiota as efficacy tool in endocrine, metabolic, and immune disorders

Articolo
Data di Pubblicazione:
2020
Abstract:
The current treatment and prevention of oral disorders follow a very sectoral control and procedures considering mouth and its structures as system completely independent from the rest of the body. The main therapeutic approach is carried out on just to keep the levels of oral bacteria and hygiene in an acceptable range compatible with one-way vision of oral-mouth health completely separated from a systemic microbial homeostasis (eubiosis vs dysbiosis). This can negatively impact on the diagnosis of more complex systemic disease and its progression. Dysbiosis is consequence of oral and gut microbiota unbalance with consequences, as reported in current literature, in cardio vascular disease, diabetes mellitus, rheumatoid arthritis, and Alzheimer's disease. Likewise, there is the need to highlight and develop a novel philosophical approach in the treatments for oral diseases that will necessarily involve non-conventional approaches.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
central nervous system (CNS) diseases; probiotics; gut dysbiosis; macrophages; oral dysbiosis; periodontal disease
Elenco autori:
Isacco, Ciro Gargiulo; Ballini, Andrea; De Vito, Danila; Nguyen, Kieu Cao Diem; Bottalico, Lucrezia; Quagliuolo, Lucio; Boccellino, Mariarosaria; Di Domenico, Marina; Santacroce, Luigi; Arrigoni, Roberto; Dipalma, Gianna; Inchingolo, Francesco; Cantore, Stefania
Autori di Ateneo:
BALLINI ANDREA
BOCCELLINO MARIAROSARIA
CANTORE STEFANIA
DIPALMA GIANNA
Link alla scheda completa:
https://iris.unilink.it/handle/20.500.14085/20822
Pubblicato in:
ENDOCRINE, METABOLIC & IMMUNE DISORDERS. DRUG TARGETS
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.6.0.0